Testim Lawsuit Claims Multiple Strokes Caused by Use of Low Testosterone Treatment Drug Notes Wright & Schulte LLC

Testim Lawsuits Rise As Louisiana Man Claims Low Testosterone Therapy Caused Him To Suffered Multiple Strokes After Using the "Low T" Treatment Drugs AndroGel and Testim

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Testim Lawsuit

Testim Lawsuit Alleged Multiple Strokes Caused by "Low T" Treatment Drug

If your believe you have suffered cardiovascular problems due to testosterone therapy drugs such as Androgel and Testim, Call Wright & Schulte LLC today for a Free Legal Evaluation at 1-800-399-0795 or by visiting www.yourlegalhelp.com

New York, NY (PRWEB) April 21, 2014

Another Testim lawsuit, this one filed in Louisiana (case no.2-14-cv-00839), is claiming low testosterone therapy is behind the multiple strokes suffered by a Jefferson Parish man. Wright & Schulte LLC recently learned of the Testim lawsuit while investigating other Testim and Adrogel Lawsuits (In Re: AndroGel Product Liability Litigation, MDL Docket No. 36).

Wright & Schulte LLC has learned that this Testim lawsuit alleges the use of AndroGel and Testim caused the plaintiff to suffer two strokes. The testosterone treatment complaint, filed April 10, 2014, in U.S. District Court for the Eastern District of Louisiana, seeks damages from AbbVie Inc. and Abbot Laboratories, which manufactures and markets AndroGel, and Auxilium Pharmaceuticals, Inc., the maker of Testim. The complaint accuses the companies of misrepresenting their products as safe, easy to use and free from serious side effects. (case no. 2-14-cv-00839000)

The court documents further state, the plaintiff experienced symptoms to which he attributed to low testosterone based on the defendants’ advertisements. The complaint also contends the plaintiff was prescribed AndroGel and Testim in 2006 when he was 63 years old and continued taking the topical gel products until 2014. The Testim lawsuit further purports that prior to taking the testosterone treatment, he had not had cardiac problems and had he known about the potential risks associated with the therapy, as reported by the FDA Safety Announcement, he would not have had to suffer the serious side effects of the medication. The AndroGel and Testim lawsuit cited a study published in the August 2013 issue of the American Medical Association which found that men who were prescribed testosterone treatment had no evidence of low testosterone, also known as hypogonadism.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]

The firm continues to review potential side-effects of low testosterone therapy drugs such as Androgel and Testim in the wake of a recent FDA warning that "Low T" drugs have the potential to cause heart attacks and strokes. Wright & Schulte LLC continues to offer free legal consults to people who believe they have suffered cardiac issues due to the use of Androgel or Testim at yourlegalhelp.com or by calling 1-800-399-0795.

Testosterone Drugs Under Scrutiny by FDA
The U.S. Food & Drug Administration (FDA) approved AndroGel in February 2000, and Testim in October 2002, for use in men who had low testosterone or who could no longer produce testosterone. In May 2009, the agency required the makers of the two prescription drugs to include boxed warnings on the labels of the two topical gel products after receiving reports that children have adverse effects when they are inadvertently exposed to the medication through contact with someone who was taking testosterone replacement therapy. By January 31, 2014, the FDA announced that it was launching an investigation into testosterone replacement therapies based on two studies that found older men or men with pre-existing heart conditions who use these drugs, might be at a higher risk of having strokes, heart attacks and even death.
[fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm189806.htm, 2009]

Testim Lawsuits
According to court documents, this Testim complaint follows three similar Testim lawsuits filed in the Philadelphia Court of Common Pleas over the "Low T" drug Testim. In one case an Alabama man contends the testosterone gel caused him to suffer neurologic impairment and cognitive deficits and impairment (case no.140301684). In the second Testim complaint (case no 1403025370 a plaintiff from New Jersey alleged that he had a heart attack as a result of using Testim. In the third complaint, filed March 21, a Pennsylvania resident alleged that he had to have heart bypass surgery due to using Testim and AndroGel. (case no. 140303508)

Also in March, plaintiffs in federal testosterone replacement therapy lawsuits asked the U.S. Judicial Panel on Multidistrict Litigation in a petition to consolidate all federally filed AndroGel lawsuits in the Northern District of Illinois. The plaintiffs alleged in their complaints that taking AndroGel caused them to have strokes, heart attacks and other health problems. [In Re: AndroGel Product Liability Litigation, MDL Docket No. 36].

Men who used AndroGel, Testim or a similar drug may be eligible to file their own low testosterone therapy lawsuit if they experienced serious and life-threatening cardiovascular events during treatment. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Lipitor lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Wright & Schulte LLC
Like Us On Facebook Follow Us On Twitter


Follow us on: Contact's Google Plus